Last 12 months
Inside the activity.
5 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2020 Filed Apr 25, 2020 00:38 UTC |
Schimmel LawrenceDirector · Chief Medical Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 6,288 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793716-20-000001 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,288 Underlying: Common Stock · 6,288 shares Expires 2030-01-27 Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:31 UTC |
Breslin Terence MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793402-20-000001 · primary_doc.xml · derivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:18 UTC |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 7,800 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001296807-20-000001 · primary_doc.xml · derivative · entry 2 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2027-01-27 Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:18 UTC |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001296807-20-000001 · primary_doc.xml · derivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| January 27, 2020 Filed Apr 25, 2020 00:11 UTC |
Meiri DavidDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793394-20-000001 · primary_doc.xml · derivative · entry 1 Meiri David · CIK 0001793394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| January 27, 2020 Filed Apr 28, 2020 15:33 UTC Amendment |
Hosseinion WarrenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001438327-20-000002 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,590 Underlying: Common Stock · 100,000 shares Expires 2030-01-27 F1 · balance_after: Amended to correct number of derivative securities beneficially owned following reported transaction. Read SEC document |
| January 27, 2020 Filed Apr 28, 2020 15:27 UTC |
Creem MitchellDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001572821-20-000001 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,120 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| January 27, 2020 Filed Apr 28, 2020 15:18 UTC Amendment |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001296807-20-000002 · primary_doc.xml · derivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,031 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. F2 · balance_after: Amended to correct number of derivative securities beneficially owned following reported transaction. Read SEC document |
| January 27, 2020 Filed Apr 28, 2020 14:35 UTC |
Hosseinion WarrenDirector
|
PurchaseDirector Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001438327-20-000001 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-01-27 Read SEC document |
| January 27, 2020 Filed Apr 29, 2020 19:10 UTC |
Fawcett MarkDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000002 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,718 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| January 27, 2020 Filed Dec 21, 2021 18:10 UTC |
Hosseinion WarrenDirector · Chief Executive Officer
|
PurchaseDirector Stock Option (right to buy) · Derivative | 800,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001486189-21-000013 · primary_doc.xml · derivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires not disclosed F2 · derivative.exercise_price: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 F2 · date: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 F2 · price: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 F2 · derivative.exercise_date: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 F2 · derivative.expiration_date: 100,000 options at $1.50 exercise date 01/27/2020 expiration date 01/27/2030 100,000 options at $1.50 exercise date 05/11/2020 expiration date 05/11/2027 600,000 options at $1.61 exercise date 01/28/2021 expiration date 01/28/2030 Read SEC document |
| November 19, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
PurchaseWarrant · Derivative | 50,000 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 6 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,236 Underlying: Common Stock · 50,000 shares Expires 2025-10-31 F4 · security: The Convertible Promissory Note and Warrant with the transaction date of 11/19/2019 comprise a single Unit, with the purchase price of $100,000 per Unit, for an aggregate $100,000. Read SEC document |
| November 19, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
PurchaseConvertible Promissory Note · Derivative | 1 | $100,000.00 Strike: $5.56 | $100,000.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 5 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,236 Underlying: Common Stock · 17,986 shares Expires 2020-10-31 F4 · security: The Convertible Promissory Note and Warrant with the transaction date of 11/19/2019 comprise a single Unit, with the purchase price of $100,000 per Unit, for an aggregate $100,000. Read SEC document |
| November 15, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
PurchaseWarrant · Derivative | 16,250 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 4 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,250 Underlying: Common Stock · 16,250 shares Expires 2025-10-31 F3 · price: The Reporting Person acquired the 11/15/2019 Convertible Debenture and Warrant for an aggregate price of US $32,500. Read SEC document |
| November 15, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
PurchaseConvertible Debenture · Derivative | 1 | $32,500.00 Strike: $1.25 | $32,500.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 3 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2020-10-31 F3 · price: The Reporting Person acquired the 11/15/2019 Convertible Debenture and Warrant for an aggregate price of US $32,500. Read SEC document |
| November 15, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
OtherWarrant · Derivative | 50,000 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 2 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2021-10-10 F1 · security: The Convertible Debenture and Warrant with the transaction date of 6/24/2019 comprise a single Unit, with the purchase price of $25,000 per Unit, for an aggregate $25,000. F2 · price: The Issuer redeemed the Convertible Debenture and Warrant in connection with the merger of Clinigence Holdings, Inc. and iGambit, Inc. on October 29, 2019, resulting in a redemption of all Convertible Debentures and Warrants held. Read SEC document |
| November 15, 2019 Filed Dec 5, 2019 23:35 UTC |
Waters John JDirector
|
OtherConvertible Debenture · Derivative | 1 | $25,000.00 Strike: $0.01 | $25,000.00 |
DisclosureSEC source: 0001567619-19-022698 · doc1.xml · derivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000,000 shares Expires 2019-10-10 F1 · security: The Convertible Debenture and Warrant with the transaction date of 6/24/2019 comprise a single Unit, with the purchase price of $25,000 per Unit, for an aggregate $25,000. F2 · price: The Issuer redeemed the Convertible Debenture and Warrant in connection with the merger of Clinigence Holdings, Inc. and iGambit, Inc. on October 29, 2019, resulting in a redemption of all Convertible Debentures and Warrants held. Read SEC document |
| March 21, 2019 Filed Dec 21, 2021 18:26 UTC |
Fawcett MarkDirector
|
PurchaseWarrants to Puchase common stock · Derivative | 3,598 | $6.67 Strike: $6.67 | $23,998.66 |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · derivative · entry 3 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,598 Underlying: Common Stock · 3,598 shares Expires 2024-12-31 Read SEC document |
| March 19, 2019 Filed Dec 21, 2021 18:10 UTC |
Hosseinion WarrenDirector · Chief Executive Officer
|
PurchaseWarrants to Puchase common stock · Derivative | 21,590 | $6.67 Strike: $6.67 | $144,005.30 |
DisclosureSEC source: 0001486189-21-000013 · primary_doc.xml · derivative · entry 3 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,590 Underlying: Common Stock · 21,590 shares Expires 2024-12-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.